Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy

Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy

Item
http://www.wikidata.org/entity/Q34237948
Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3Oxidative stress, inflammation, and cancer: how are they linked?15-Deoxy-Δ12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction.Cyclooxygenases and lipoxygenases in cancer.Oxidative modification of proteins: an emerging mechanism of cell signaling.Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1.Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.A novel class of mitochondria-targeted soft electrophiles modifies mitochondrial proteins and inhibits mitochondrial metabolism in breast cancer cells through redox mechanisms.Cell signalling by reactive lipid species: new concepts and molecular mechanisms.Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis15-Deoxy-Δ(12,14)-Prostaglandin J2 Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox PathwayDetection of electrophile-sensitive proteins.Nitro-fatty acid inhibition of triple negative breast cancer cell viability, migration, invasion and tumor growth.15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice.15d-PGJ2 is a new hope for controlling tumor growth.
P2860

Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy

Item
http://www.wikidata.org/entity/Q34237948
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@ast
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@en
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@nl
type
label
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@ast
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@en
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@nl
prefLabel
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@ast
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@en
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Modulation of mammary cancer c ...... ns for anti-metastatic therapy
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932